MedPath

Effect of Azithromycine (AZM) on gingival overgrowth

Phase 3
Conditions
gingival enlargement.
gingival fibromatosis
Registration Number
IRCT2017040529321N2
Lead Sponsor
Vice Chancellor for Research, Kerman university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
24
Inclusion Criteria

transplanted patients with systemic use of CsA; more than 18 year old; existing upper and lower 6 teeth of anterior segment; gingival overgrowth in grade 1 based on King Index; plaque index more than 10%
Exclusion criteria: hypersensitivity for macrolid antibiotics; not having stable renal function; having any periodontal treatment after transplantation; local irritation in Maxiillary and Mandibular anterior teeth; Oral breathing; smoking

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gingival enlargement. Timepoint: Before intervention, 4,8,12,16 weeks after intervention. Method of measurement: Periodontal probe.
Secondary Outcome Measures
NameTimeMethod
Gingivitis. Timepoint: Before intervention, 4, 8, 12, 16 weeks after intervention. Method of measurement: Observation, periodontal probe.;Dental plaque. Timepoint: Before intervention, 4, 8, 12, 16 weeks after intervention. Method of measurement: observation, plaque disclosing tablet.;Clinical crown length. Timepoint: before intervention, 4, 8, 12, 16 weeks after intervention. Method of measurement: Periodontal probe.;Probing depth. Timepoint: Before intervention, 4, 8, 12, 16 weeks after intervention. Method of measurement: periodontal probe.
© Copyright 2025. All Rights Reserved by MedPath